News
June 12, 2019
The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the Final Report of the Advisory Council on the Implementation of National Pharmacare:
May 29, 2019
New data released today by the federal government’s Patented Medicine Prices Review Board (PMPRB) shows that in 2018 Canadian prices for generic prescription medicines dropped to five percent below average or mean prices in comparator countries.
May 29, 2019
New data released today by the federal government’s Patented Medicine Prices Review Board (PMPRB) shows that in 2018 Canadian prices for generic prescription medicines dropped to five percent below average or mean prices in comparator countries.
March 19, 2019
Toronto, March 19, 2019 – The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on Federal Budget 2019.
March 6, 2019
Toronto, March 6, 2019 – The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the Interim report from the Advisory Council on the Implementation of National Pharmacare.